CA-HILLSTONE-NETWORKS
24.1.2023 08:01:36 CET | Business Wire | Press release
Hillstone Networks, a leading provider of innovative and accessible cybersecurity solutions, has announced a major upgrade to its operating system, Hillstone StoneOS 5.5R10. The latest upgrade delivers AI-based high performance threat protection, centralized Zero Trust control and management, and further simplification of security operations and system optimization, among over 300 new features. The new functionality enhances the security posture of customer environments and further streamlines security operations with an easy upgrade path.
Threat protection enhancements with AI technology
The new StoneOS leverages AI technology to provide ML-based threat detection for encrypted traffic without the need for decryption. It also features intelligent DDoS protection and DGA detection. In addition, included is a blacklist extension that empowers the Perimeter Traffic Filtering (PTF) function and delivers more protection against threats.
Centralized Zero Trust control and management
Advanced ZTNA implements centralized management for ZTNA policies through Hillstone Security Management (HSM), and supports intelligent connection to ZTNA gateways, single packet authentication (SPA), multiple vendor Operating System support for ZTNA clients, along with a ZTNA portal. The new features provide a better user experience with improved overall operations and management of the ZTNA solution.
Smarter interconnectivity with extended VPN capabilities
The extended VPN features support ECMP and failover for intelligent VPN routing and provide IPSec VPN tunnel establishment options by configuring custom ports and auto-negotiation. These features bring better bandwidth utilization and improve connectivity, ensuring the business remains undisrupted.
Streamlined system operations offload redundant workloads
The latest StoneOS introduces a simplified start-up wizard and automated NAT redundancy check to facilitate system operations, improving overall productivity for organizations by streamlining the workload of system administrators.
Robust system-wide enhancements further ensure business continuity
System availability is improved across the board in the latest release, with support for advanced High Availability (HA) and the graceful restart of Border Gateway Protocol (BGP), further ensuring that business services remain uninterrupted for organizations.
“The transition from the traditional, edge-based security model to the distributed workforce model is a seismic change, triggered primarily by the pandemic-induced work from home mandate, but the impact will evolve gradually, and therefore the solutions we deliver need to address the associated challenges,” states Tim Liu, CTO and co-founder, Hillstone Networks, “The latest iteration of StoneOS continues to address the challenges faced by SecOps teams, and the constant risks faced by enterprises globally. Enhanced AI-driven threat protection, better integration, centralized control and management, and streamlined operations are all critical in delivering a stable and strategic approach to cyber-resilient cybersecurity environments.”
StoneOS is the foundation for all Hillstone next-generation firewalls, which has been recognized in the 2022 Gartner® Magic Quadrant™ for Network Firewalls for the 9th consecutive year as a Visionary. StoneOS 5.5R10 is now generally available.
About Hillstone Networks
Hillstone Networks’ innovative and accessible cybersecurity solutions reshape enterprise security, enabling cyber resilience while lowering TCO. By providing comprehensive visibility, superior intelligence, and rapid protection to see, understand, and act against multilayer, multistage cyber threats, Hillstone is favorably rated by leading analysts and trusted by global companies. To learn more visit www.hillstonenet.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005067/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom